The Present study an attempt was made to formulate glipizide loaded microspheres using Gelatin as a mucoadhesive polymer by emulsion cross linking method using 25%v/v glutaraldehyde as a cross linking agent for management of type 2 diabetes mellitus. The literature survey reveals that extensive research has been carried out on development of mucoadhesive microspheres containing anti-diabetic drug by various methods. It is noteworthy that there was no literature review available describing the formulation of glipizide loaded mucoadhesive microspheres prepared using Gelatin hence the study was further preceded. In formulations were prepared using gelatin as a polymer (1:20, 1:15, 1:10, 1:7.5, 1:5 and 1:2.5) in six different ratios. T...
Type 2 diabetes mellitus (T2DM) is the most common form of diabetes constituting 90% of the diabetic...
Glipizide is a potent, rapid-acting with short duration of action and well tolerated second-generati...
The aim of this study was to formulate gliclazide loaded controlled release microspheres. Microspher...
Mucoadhesion is defined as the adhesion of synthetic or biological macromolecules to the biological ...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated gl...
For many decades, medications of an acute disease or a chronic illness has been accomplished by deli...
Objective: The purpose of this research was to formulate and evaluate floating microsphere of glipiz...
Objective: The objective of the present study was to formulate sustained release glipizide loaded mi...
The objective of this study was to develop glipizide microsphere with natural gums. Guar gum and xan...
The objective of the present study was to develop Gliclazide microspheres in order to achieve an ext...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
Glipizide is one of the most widely used oral hypoglycemic agents in the control of diabetes mellitu...
Type 2 diabetes mellitus (T2DM) is the most common form of diabetes constituting 90% of the diabetic...
Glipizide is a potent, rapid-acting with short duration of action and well tolerated second-generati...
The aim of this study was to formulate gliclazide loaded controlled release microspheres. Microspher...
Mucoadhesion is defined as the adhesion of synthetic or biological macromolecules to the biological ...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated gl...
For many decades, medications of an acute disease or a chronic illness has been accomplished by deli...
Objective: The purpose of this research was to formulate and evaluate floating microsphere of glipiz...
Objective: The objective of the present study was to formulate sustained release glipizide loaded mi...
The objective of this study was to develop glipizide microsphere with natural gums. Guar gum and xan...
The objective of the present study was to develop Gliclazide microspheres in order to achieve an ext...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
Glipizide is one of the most widely used oral hypoglycemic agents in the control of diabetes mellitu...
Type 2 diabetes mellitus (T2DM) is the most common form of diabetes constituting 90% of the diabetic...
Glipizide is a potent, rapid-acting with short duration of action and well tolerated second-generati...
The aim of this study was to formulate gliclazide loaded controlled release microspheres. Microspher...